| Outcome Measures: |
Primary: postprandial glycaemia, measured by Self Monitoring of Blood Glucose, 2 hours after eating during 4 weeks | Secondary: adverse events, Throughout the study (4 weeks)|severe hypoglycaemia frequency, Throughout the study (4 weeks)|insulin doses, basal rate and boluses|mean glycaemia, data from Self Monitoring of Blood Glucose, before eating and 2 hours after eating during 4 weeks|standard deviation of glycaemia, data from Self Monitoring of Blood Glucose, before eating and 2 hours after eating during 4 weeks|frequency of glycaemia < or = 60mg/dl, data from Self Monitoring of Blood Glucose, before eating and 2 hours after eating during 4 weeks|frequency of glycaemia between 61-140mg/dl, data from Self Monitoring of Blood Glucose, before eating and 2 hours after eating during 4 weeks|frequency of glycaemia >140mg/dl, data from Self Monitoring of Blood Glucose, before eating and 2 hours after eating during 4 weeks|mean glycemia, data from Continue Glycemia Monitoring, Throughout the day during 4 weeks|standard deviation, data from Continue Glycemia Monitoring, Throughout the day during 4 weeks|time spent within glucose range < or = 60mg/dl, data from Continue Glycemia Monitoring, Throughout the day during 4 weeks|time spent within glucose range between 61-140mg/dl, data from Continue Glycemia Monitoring, Throughout the day during 4 weeks|time spent within glucose range mg/dl, data from Continue Glycemia Monitoring, Throughout the day during 4 weeks|fructosamine, day 1|fructosamine, day 1 + 2 weeks|fructosamine, day 1 + 4 weeks
|
| Locations: |
University Hospital Toulouse Rangueil, Toulouse, Haute Garonne, 31059, France|Saint-André Hospital, Bordeaux, 33000, France|Lapeyronie Hospital, Montpellier, 34295, France
|
